Description
A cinnamic acid derivative that has antidiabetic activity; activates α1-adrenergic receptors (IC50 = 1.4 µM) to enhance secretion of β-endorphin (EC50 = 52.2 nM); increases glucose uptake and enhances glycogen synthesis in isolated soleus muscles of streptozocin-induced diabetic rats; induces a dose-dependent reduction in plasma glucose levels in streptozocin-induced diabetic rats; inhibits absorbance of intestinal maltase and sucrose via α-glucosidase in vitro. (IC50s = 760 and 450 µM, respectively)
Formal name: 3-(3-hydroxy-4-methoxyphenyl)-2-propenoic acid
Synonyms: 3-methoxy Caffeic Acid|3-hydroxy-4-Methoxycinnamic Acid|NSC 51987
Molecular weight: 194.2
CAS: 537-73-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes